StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3017% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2012 it was $12.04M, down 5.5% from the year before.

Annual ebitda

PeriodPeriod endValueChange
FY2012Dec 31, 2012$12.04M-5.5%
FY2011Dec 31, 2011$12.73M-9.9%
FY2010Dec 31, 2010$14.14M–

More Harvard Bioscience figures

See a number that looks wrong?